December 15, 2010 – Definiens and aycan have formed a partnership to complete the first joint project to quantify and analyze lung tumors.
Under the partnership, Definiens has combined its LungExpert with aycan’s OsiriX PRO to create a workstation that quantifies lung tumors according to RECIST and WHO guidelines and also by their volume. This new integrated solution enables efficient analysis of lesions, including automated quantification of lung tumors.
The new workstation is expected to be available in early 2011.
For more information: www.aycan.com, www.definiens.com
Additional Content
News | Ultrasound Imaging
Nov. 3, 2026 — GE HealthCare has announced two new AI-assisted capabilities for its Vscan Air handheld ultrasound system ...
November 03, 2026 
May 4, 2026 — Esaote presented the latest developments of I-Genius* — an open MRI system designed to provide multiple ...
May 05, 2026 
News | Stroke
March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...
March 11, 2026 
News | Radiation Oncology
March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...
March 05, 2026 
News | Radiation Therapy
Feb. 26, 2026 — GT Medical Technologies, a company focused on improving the lives of patients with brain tumors, has ...
February 27, 2026 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now